Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.

Aft RL, Lewis JS, Zhang F, Kim J, Welch MJ.

Cancer Res. 2003 Sep 1;63(17):5496-504.

PMID:
14500386
[PubMed - indexed for MEDLINE]
Free Article
2.

[(64)Cu]diacetyl-bis(N(4)-methyl-thiosemicarbazone) - a radiotracer for tumor hypoxia.

Wood KA, Wong WL, Saunders MI.

Nucl Med Biol. 2008 May;35(4):393-400. doi: 10.1016/j.nucmedbio.2008.02.002. Epub 2008 Apr 3. Review.

PMID:
18482676
[PubMed - indexed for MEDLINE]
3.

Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.

Bourgeois M, Rajerison H, Guerard F, Mougin-Degraef M, Barbet J, Michel N, Cherel M, Faivre-Chauvet A.

Nucl Med Rev Cent East Eur. 2011;14(2):90-5. Review.

PMID:
22219149
[PubMed - indexed for MEDLINE]
Free Article
4.

Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.

Dwarakanath BS.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S27-31. doi: 10.4103/0973-1482.55137. Review.

PMID:
20009290
[PubMed - indexed for MEDLINE]
Free Article
5.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
6.

Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Holland JP, Lewis JS, Dehdashti F.

Q J Nucl Med Mol Imaging. 2009 Apr;53(2):193-200. Review.

PMID:
19293767
[PubMed - indexed for MEDLINE]
Free Article
7.

Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.

Gupta S, Farooque A, Adhikari JS, Singh S, Dwarakanath BS.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S16-20. doi: 10.4103/0973-1482.55135. Review.

PMID:
20009287
[PubMed - indexed for MEDLINE]
Free Article
8.

PET imaging of tumour hypoxia.

Padhani A.

Cancer Imaging. 2006 Oct 31;6:S117-21. Review. Retraction in: Cancer Imaging. 2007;7:1.

PMID:
17114063
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors.

St Croix B, Man S, Kerbel RS.

Cancer Lett. 1998 Sep 11;131(1):35-44. Review.

PMID:
9839618
[PubMed - indexed for MEDLINE]
10.

PET imaging of hypoxia.

Lewis JS, Welch MJ.

Q J Nucl Med. 2001 Jun;45(2):183-8. Review.

PMID:
11476169
[PubMed - indexed for MEDLINE]
11.

Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.

Dwarakanath BS, Singh D, Banerji AK, Sarin R, Venkataramana NK, Jalali R, Vishwanath PN, Mohanti BK, Tripathi RP, Kalia VK, Jain V.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S21-6. doi: 10.4103/0973-1482.55136. Review.

PMID:
20009289
[PubMed - indexed for MEDLINE]
Free Article
12.

Hypoxia imaging agents labeled with positron emitters.

Hoigebazar L, Jeong JM.

Recent Results Cancer Res. 2013;194:285-99. doi: 10.1007/978-3-642-27994-2_15. Review.

PMID:
22918765
[PubMed - indexed for MEDLINE]
13.

Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.

Farooque A, Afrin F, Adhikari JS, Dwarakanath BS.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S32-5. doi: 10.4103/0973-1482.55138. Review.

PMID:
20009291
[PubMed - indexed for MEDLINE]
Free Article
14.

Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion.

Rockwell S, Kelley M, Irvin CG, Hughes CS, Porter E, Yabuki H, Fischer JJ.

Radiother Oncol. 1991 Oct;22(2):92-8. Review.

PMID:
1957007
[PubMed - indexed for MEDLINE]
15.

Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.

Paterson BM, Donnelly PS.

Chem Soc Rev. 2011 May;40(5):3005-18. doi: 10.1039/c0cs00215a. Epub 2011 Mar 15. Review.

PMID:
21409228
[PubMed - indexed for MEDLINE]
16.

Imaging hypoxia in tumors.

Ballinger JR.

Semin Nucl Med. 2001 Oct;31(4):321-9. Review.

PMID:
11710774
[PubMed - indexed for MEDLINE]
17.

Novel chelating agents for potential clinical applications of copper.

Ma D, Lu F, Overstreet T, Milenic DE, Brechbiel MW.

Nucl Med Biol. 2002 Jan;29(1):91-105. Review.

PMID:
11786280
[PubMed - indexed for MEDLINE]
18.

Copper radionuclides and radiopharmaceuticals in nuclear medicine.

Blower PJ, Lewis JS, Zweit J.

Nucl Med Biol. 1996 Nov;23(8):957-80. Review.

PMID:
9004284
[PubMed - indexed for MEDLINE]
19.

Chemical radiosensitizers in cancer therapy.

Shenoy MA, Singh BB.

Cancer Invest. 1992;10(6):533-51. Review.

PMID:
1422891
[PubMed - indexed for MEDLINE]
20.

Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo-therapy and radiotherapy.

Gewirtz DA, Gupta MS, Sundaram S.

Curr Med Chem Anticancer Agents. 2002 Nov;2(6):683-90. Review.

PMID:
12678720
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk